miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
Elisa Callegari(University of Ferrara), Massimo Negrini(University of Bologna)
Cited by 14
Related Papers
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
|Cancer Research|2010|213
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
|Oncotarget|2015|29
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
|Molecular Therapy — Nucleic Acids|2018|23
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
|Cell Death Discovery|2026|2